Podcast Episodes
Back to Search
Episode 46: Persistence and Planning Pays Off
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the r…
6 years, 6 months ago
Episode 45: Getting Drug Approval Through FDA LPAD
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for An…
6 years, 7 months ago
Episode 44: Annual Pipeline Report
Pharm Exec editors discuss the articles they focused on for the November Annual Pipeline Report.
6 years, 7 months ago
Episode 43: Pharma Reputation
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
6 years, 8 months ago
Episode 42: Establishing a New Drug Therapy
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering sp…
6 years, 8 months ago
Episode 41: The Patient Journey
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in reg…
6 years, 9 months ago
Episode 40: Global Pharma Outlook
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his fi…
6 years, 9 months ago
Episode 39: CEO Builds Business With Compassion
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with editors about his unusual pharma journey, which has included research, clinical work, and…
6 years, 10 months ago
Episode 38: Customer-Centric Innovation
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centr…
6 years, 10 months ago
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncolog…
6 years, 11 months ago